UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000020969
Receipt No. R000024193
Official scientific title of the study Vessel imaging by indocyanine green fluorescence
Date of disclosure of the study information 2016/02/10
Last modified on 2016/08/11 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Vessel imaging by indocyanine green fluorescence
Title of the study (Brief title) Vessel imaging by ICG fluorescence
Region
Japan

Condition
Condition Hepatobiliary pancreatic surgery
Classification by specialty
Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To investigate arterio/portography by indocyanine green fluorescence imaging
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Comparison between actual and visualized vessels by indocyanine green fluorescence imaging
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 Arterio/portography via vinous injection of ICG and visualized using infra-red.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria HBP surgery
written informed consent
Key exclusion criteria Allergy against ICG
Target sample size 100

Research contact person
Name of lead principal investigator Shogo Kobayashi
Organization Osaka medical center for cancer and cardiovascular diseases
Division name Surgery
Address 1-3-3, Nakamichi, Higashinari, Osaka, 537-8511, JAPAN
TEL +81669721181
Email s-kobayashi@umin.ac.jp

Public contact
Name of contact person Shogo Kobayashi
Organization Osaka medical center for cancer and cardiovascular diseases
Division name Surgery
Address 1-3-3, Nakamichi, Higashinari, Osaka, 537-8511, JAPAN
TEL +81669721181
Homepage URL
Email s-kobayashi@umin.ac.jp

Sponsor
Institute Osaka medical center for cancer and cardiovascular diseases
Institute
Department

Funding Source
Organization Osaka medical center for cancer and cardiovascular diseases
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 02 Month 10 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2016 Year 02 Month 04 Day
Anticipated trial start date
2016 Year 02 Month 04 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 02 Month 10 Day
Last modified on
2016 Year 08 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024193